Hikma Pharmaceuticals PLC (LON:HIK)
1,947.00
-8.00 (-0.41%)
May 13, 2025, 4:35 PM BST
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Injectables | 967.78M |
Log In |
Log In |
Log In |
Log In |
Injectables Growth | 4.48% |
Log In |
Log In |
Log In |
Log In |
Generics | 753.79M |
Log In |
Log In |
Log In |
Log In |
Generics Growth | 38.17% |
Log In |
Log In |
Log In |
Log In |
Branded | 574.39M |
Log In |
Log In |
Log In |
Log In |
Branded Growth | 2.39% |
Log In |
Log In |
Log In |
Log In |
Other | 16.89M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 60.07% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
United States | 1.39B |
Log In |
Log In |
Log In |
Log In |
United States Growth | 19.35% |
Log In |
Log In |
Log In |
Log In |
Middle East and North Africa | 294.44M |
Log In |
Log In |
Log In |
Log In |
Middle East and North Africa Growth | -4.31% |
Log In |
Log In |
Log In |
Log In |
Saudi Arabia | 209.97M |
Log In |
Log In |
Log In |
Log In |
Saudi Arabia Growth | 7.76% |
Log In |
Log In |
Log In |
Log In |
Europe and Rest of the World | 165.72M |
Log In |
Log In |
Log In |
Log In |
Europe and Rest of the World Growth | -2.79% |
Log In |
Log In |
Log In |
Log In |
Algeria | 152.05M |
Log In |
Log In |
Log In |
Log In |
Algeria Growth | 41.88% |
Log In |
Log In |
Log In |
Log In |
Egypt | 74.82M |
Log In |
Log In |
Log In |
Log In |
Egypt Growth | -19.86% |
Log In |
Log In |
Log In |
Log In |
North America | 18.50M |
Log In |
Log In |
Log In |
Log In |
United Kingdom | 8.85M |
Log In |
Log In |
Log In |
Log In |
United Kingdom Growth | 36.25% |
Log In |
Log In |
Log In |
Log In |